ACTINOBAC BIOMED

Actinobac Biomed focuses on the development of pharmaceutical technologies derived from agents that target Leukocyte Function Antigen-1 (LFA-1). The company's lead product, Leukotoxin, is a bacterial toxin that specifically targets white blood cells. In addition to its use as an effective targeted therapy agent for the treatment of hematologic malignancies, abundant evidence in literature suggests that Leukotoxin, or a derived product, can effectively be used to treat infectious diseases suc... h as HIV/AIDS and tuberculosis, as well as many autoimmune diseases including rheumatoid arthritis, multiple sclerosis, Crohnรขโฌโขs disease, type 1 diabetes, Lupus and psoriasis. Therefore, the company will direct its efforts in three strategic areas. The first, and highest priority, is the development of Leukotoxin as a protein therapeutic for the treatment of hematologic malignancies. The second will focus on the use of Leukotoxin and derived therapeutic peptides or mimetics for the treatment of significant diseases other than hematologic malignancies, including infections and autoimmune diseases. The third area represents an early-stage drug discovery program with Magellan BioScience that will maintain a healthy pipeline of novel therapeutic agents.
ACTINOBAC BIOMED
Social Links:
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2009-01-01
Address:
North Brunswick, New Jersey, United States
Country:
United States
Website Url:
http://www.actinobac.com
Total Employee:
11+
Status:
Active
Contact:
(732)422-1083
Email Addresses:
[email protected]
Total Funding:
6 M USD
Technology used in webpage:
U.S. Server Location
Similar Organizations
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focusesย on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Imvax
Imvax is a biotechnology company focused on the development of novel patient-specific vaccines and immunotherapy strategies.
KSQ Therapeutics
KSQ Therapeutics is using CRISPR technology within a powerful drug discovery engine to enable high-confidence drug development.
Slingshot Biosciences
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
Current Advisors List
Current Employees Featured
Founder
Investors List
Kairos Ventures
Kairos Ventures investment in Venture Round - Actinobac Biomed
Foundation Venture Capital Group
Foundation Venture Capital Group investment in Seed Round - Actinobac Biomed
Foundation Venture Capital Group
Foundation Venture Capital Group investment in Seed Round - Actinobac Biomed
Official Site Inspections
http://www.actinobac.com
- Host name: 172.67.136.54
- IP address: 172.67.136.54
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago

More informations about "Actinobac Biomed"
Actinobac Biomed Inc. | Therapy from Life
Actinobac Biomed Inc. | Therapy from LifeSee details»
Actinobac Biomed - Crunchbase Company Profile & Funding
Actinobac Biomed focuses on the development of pharmaceutical technologies derived from agents that target Leukocyte Function Antigen-1 (LFA-1). The company's lead product, โฆSee details»
Actinobac Biomed, Inc. - LinkedIn
Actinobac Biomed, Inc. is a New Jersey based company with headquarters in North Brunswick. The current focus of its activities involves the development of pharmaceutical technologies based upon ...See details»
Actinobac Biomed, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Actinobac Biomed, Inc. of Princeton, NJ. Get the latest business insights from Dun & Bradstreet.See details»
Actinobac Biomed - PitchBook
Actinobac Biomed General Information Description. Developer of pharmaceutical technologies designed to target white blood cell diseases. The company's technologies develop agents for โฆSee details»
Actinobac Biomed Company Profile - Office Locations ... - Craft
Actinobac is a biopharmaceutical company developing therapeutics for multiple indications, including blood cancers, autoimmune/inflammatory diseases, and HIV. The Company's drug โฆSee details»
Actinobac Biomed Company Profile | Management and Employees โฆ
Actinobac Biomed, Inc. operates as a biopharmaceutical company that develops therapeutics for multiple indications, including blood cancers, autoimmune/inflammatory diseases, and HIV. โฆSee details»
Actinobac Biomed, Inc. Overview | SignalHire Company Profile
Actinobac Biomed, Inc. is a private company that has been in the industry for 14 years. The company currently specializes in the Pharmaceuticals, Pharmaceuticals areas ... Organization โฆSee details»
Actinobac Biomed - Overview, News & Similar companies
Who is Actinobac Biomed. Actinobac Biomed, Inc. operates as a biopharmaceutical company that develops therapeutics for multiple indications, including blood cancers, autoim โฆSee details»
Actinobac Biomed Company Profile Funding & Investors
Led by Dr Scott Kachlany, Actinobac Biomed is a biopharmaceutical company developing therapeutics for multiple indications, including blood cancers, autoimmune/inflammatory โฆSee details»
ACTINOBAC BIOMED, INC. - CAGE.report
ACTINOBAC BIOMED, INC. DUNS 829616676 / 82-961-6676. NCAGE Code: 5BY82. ACTINOBAC BIOMED, INC. NCAGE Code: 6YG68. ACTINOBAC BIOMED, INC.!DBA USE โฆSee details»
Actinobac Biomed - Funding, Financials, Valuation & Investors
Actinobac Biomed is funded by 2 investors. Kairos Ventures and Foundation Venture Capital Group are the most recent investors. Actinobac Biomed has a post-money valuation in the โฆSee details»
Benjamin Belinka - President & CEO @ Actinobac Biomed
Primary Organization . Actinobac Biomed . Gender Male; The President and CEO of Actinobac Biomed is Dr. Benjamin Belinka. Dr. Belinka obtained his Ph.D. in chemistry from State โฆSee details»
Firm | SBIR
Official websites use .gov A .gov website belongs to an official government organization in the United States. Secure .gov websites use HTTPS A lock A locked padlock) or https:// means โฆSee details»
Actinobac Biomed, Inc. (Actinobac Biomed, Inc.) - ่ฏ็ฉ็ฎก็บฟ_ไธๅฉ_ โฆ
Actinobac Biomed, Inc. was founded in 2009 with financial backing from Foundation Venture Capital Group, LLC, to develop commercial products based upon technology developed at the โฆSee details»
Actinobac Biomed - Contacts, Employees, Board Members
Organization. Actinobac Biomed . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 2. Number of โฆSee details»
Actinobac Biomed, Inc., Receives Investment To Advance โฆ
NEW BRUNSWICK, N.J., July 12, 2017 /PRNewswire-USNewswire/ -- Actinobac Biomed Inc., started with an investment from Foundation Venture Capital Group (FVCG), Inc., an affiliate of โฆSee details»
Actinobac Biomed Receives Up To $4.4M Investment - FinSMEs
Jul 14, 2017 Actinobac Biomed Inc., a New Brunswick, N.J.-based biopharmaceutical company developing therapeutics for multiple indications, including blood cancers, โฆSee details»
Scott C. Kachlany - Founder & Chair of the Scientific ... - Crunchbase
Actinobac Biomed was founded by Dr. Scott C. Kachlany. Dr. Kachlany serves as Chair of the Scientific Advisory Committee. He obtained his B.S. degree from Cornell University in Ithaca, โฆSee details»
Cancer Therapy Based on Oral Bacteria Gets FDA Approval for โฆ
May 26, 2021 A company founded by Rutgers School of Dental Medicine researcher Scott Kachlany, PhD, has received US Food and Drug Administration (FDA) approval to treat cancer โฆSee details»